Patrick F Fogarty, MD
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Director, Penn Comprehensive Hemophilia and Thrombosis Program, Philadelphia, PA
Department: Medicine
Contact information
Division of Hematology/Oncology
Penn Blood Disorders Center
3rd Floor Dulles Building
3400 Spruce Street
Philadelphia, PA 19104
Penn Blood Disorders Center
3rd Floor Dulles Building
3400 Spruce Street
Philadelphia, PA 19104
Office: 215-615-6555
Fax: 215-615-6599
Fax: 215-615-6599
Education:
B.A.
University of Pennsylvania, 1992.
M.D. (Medicine)
Jefferson Medical College, 1996.
B.A.
University of Pennsylvania, 1992.
M.D. (Medicine)
Jefferson Medical College, 1996.
Post-Graduate Training
Intern, Georgetown University Medical Center, Washington, DC, 1996-1997.
Resident in Medicine, Georgetown University Medical Center, Washington, DC, 1997-1999.
Fellowship in Hematology, National Heart, Lung & Blood Institute, National Institutes of Health, Bethesda, MD, 1999-2002.
Clinical Research Fellowship, Warren Grant Magnuson Clinical Center, Hematology Section, National Institutes of Health, 2002-2004.
Intern, Georgetown University Medical Center, Washington, DC, 1996-1997.
Resident in Medicine, Georgetown University Medical Center, Washington, DC, 1997-1999.
Fellowship in Hematology, National Heart, Lung & Blood Institute, National Institutes of Health, Bethesda, MD, 1999-2002.
Clinical Research Fellowship, Warren Grant Magnuson Clinical Center, Hematology Section, National Institutes of Health, 2002-2004.
Certifications
American Board of Internal Medicine (Internal Medicine), 1999.
American Board of Internal Medicine (Hematology), 2002.
American Board of Internal Medicine (Medical Oncology), 2003.
Permanent linkAmerican Board of Internal Medicine (Internal Medicine), 1999.
American Board of Internal Medicine (Hematology), 2002.
American Board of Internal Medicine (Medical Oncology), 2003.
Selected Publications
Colace T, Panckeri K, Fogarty P, Diamond S.: A microfluidic model of in vitro hemostasis that potentiates thrombin generation via the intrinsic pathway of coagulation. International Society on Thrombosis and Haemostasis, XXIV Congress, Amsterdam. July 2013.Li S, Neelakantan S, Powell J, Josephson N, Pasi J, Perry D, Shapiro A, Ragni M, Kulkarni R, Fogarty P, Brennan A, Vigilani G, Pierce G, Jiang H, Nestorov I.: Population pharmacokinetic analysis of long-lasting recombinant factor VIII Fc fusion protein (rFVIIIFc) in patients with severe haemophilia A International Society on Thrombosis and Haemostasis, XXIV Congress, Amsterdam. July 2013.
Lane J, McLaren PJ, Dorrell L, Shianna KV, Stemke A, Pelak K, Moore S, Oldenburg J, Alvarez-Roman MT, Angelillo-Scherrer A, Boehlen F, Bolton-Maggs PH, Brand B, Brown D, Chiang E, Cid-Haro AR, Clotet B, Collins P, Colombo S, Dalmau J, Fogarty P, Giangrande P, Gringeri A, Iyer R, Katsarou O, Kempton C, Kuriakose P, Lin J, Makris M, Manco-Johnson M, Tsakiris DA, Martinez-Picado J, Mauser-Bunschoten E, Neff A, Oka S, Oyesiku L, Parra R, Peter-Salonen K, Powell J, Recht M, Shapiro A, Stine K, Talks K, Telenti A, Wilde J, Yee TT, Wolinsky SM, Martinson J, Hussain SK, Bream JH, Jacobson LP, Carrington M, Goedert JJ, Haynes BF, McMichael AJ, Goldstein DB, Fellay J; NIAID Center for HIV/AIDS Vaccine Immunology (CHAVI).: A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A. Hum Mol Genet 22(9): 1903-10, May 2013.
Fogarty PF: Chapter 4: Hemophilia A and B. Consultative Hemostasis and Thrombosis. Kitchens CS, Konkle BA, Alving BM, Kessler CM (eds.). Saunders Elsevier, 4th edition, May 1 2013 Notes: Elsevier Science Health Science Division. Expert Consult - Online and Print.
Tarantino MD, Fogarty P, Mayer B, Vasey SY, Brainsky A.: Efficacy of eltrombopag in management of bleeding symptoms associated with chronic immune thrombocytopenia. Blood Coagul Fibrinolysis 24(3): 284-296, April 2013.
J. Mahlangu, J. Powell, M. Ragni, P. Chowdary, N. Josephson, I. Pabinger-Fasching, H. Hanabusa, N. Gupta, R. Kulkarni, P. Fogarty, D. Perry, A. Shapiro, J. Pasi, S. Krassova, H. Jiang, S. Li, S. Neelakantan, F. Greblikas, J. Goyal, J. Sommer, J. Dumont, A. Innes, K. Nugent, A. Brennan, A. Luk, G. Pierce : Phase 3 Clinical Study of Recombinant Factor FVIII Fc Fusion Protein (rFVIIIFc) Demonstrated Safety, Efficacy, and Improved Pharmacokinetics (A-LONG). European Association of Hemophilia and Allied Disorders, 6th Annual Congress, Warsaw, Poland. Haemophilia. 19(Suppl.2): 10-82, February 2013.
Patrick F. Fogarty, MD: Disorders of Hemostasis I: Coagulation. Bethesda Handbook of Clinical Hematology, 3rd ed. Rodgers G, Young NS (eds.). Lippincott, Williams and Wilkins, in press 2013.
Patrick F. Fogarty, MD: Disorders of Hemostasis II. Bethesda Handbook of Clinical Hematology, 3rd ed. Rodgers G, Young NS (eds.). Lippincott, Williams and Wilkins, in press 2013.
Fogarty PF, Dunbar CE: Thrombocytopenia. Bethesda Handbook of Clinical Hematology, 3rd ed. Rodgers G, Young NS (eds.). Lippincott, Williams and Wilkins, in press 2013.
Fogarty PF, Mancuso ME, Kasthuri R, (GEHEP), Global Emerging Hemophilia Experts Panel : Presentation and Management of Acute Coronary Syndromes Among Persons with Haemophilia: a Retrospective, International, Ten-Year Survey. International Society of Thrombosis and Haemostasis SSC Meeting, Liverpool, UK(Abstract HDC-13), June 2012.
